Key facts
- It has raised $300K; the latest was Accelerator/Incubator in Sep 2025.
- Notable investors include US National Science Foundation, SOSV, IndieBio, Center for Life Science Ventures, Cornell University — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Forage Evolution
- ·The full record, as it builds
Funding rounds
No funding rounds for Forage Evolution are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Forage Evolution
Developer of a molecular biology platform designed to enable rapid and straightforward transfer of DNA into bacterial cells for biotechnology research and development. The company offers a patented host organism and proprietary formulations created through applied physics and biochemistry, enabling biotechnology researchers to improve efficiency, consistency, and throughput in laboratory research workflows.
- Sector
- Healthcare
- HQ
- Ithaca, NY, United States
- Founded
- 2024
- Employees
- 5
- Website
- forageevo.com/
- Ownership
- Privately Held (backing)
Forage Evolution doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Forage Evolution shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Forage Evolution in its N-PORT filings yet. We sweep new filings monthly.